Simba Gill's Net Worth
$209 Thousand
Who is Simba Gill?
Simba Gill does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Foghorn Therapeutics Inc., Evelo Biosciences, Inc., MAXYGEN INC, and Serina Therapeutics, Inc..
SEC CIK
Simba Gill's CIK is 0001180763
Past Insider Trading and Trends
2023 was Simba Gill's most active year for acquiring shares with 10 total transactions. Simba Gill's most active month to acquire stocks was the month of December. 2023 was Simba Gill's most active year for disposing of shares, totalling 8 transactions. Simba Gill's most active month to dispose stocks was the month of August. 2024 saw Simba Gill paying a total of $88,320.00 for 311,300 shares, this is the most they've acquired in one year. In 2023 Simba Gill cashed out on 46,827 shares for a total of $11,617.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Foghorn Therapeutics Inc. (FHTX) Snapshot price: $7.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
∞
| 34.06K |
$0.73 | $59,860.00 | 34.06K |
Sep 12 - Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.05
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.97% | 1K |
$0.33 | -$56.76 | 17.76K |
Scheduled
|
Nov 7 - Nov 8
| ||
Form 4
| +346.40% | 13K |
$3.94 | -$7,864.24 | 16.76K |
Sep 27 - Sep 28
| |||
Form 4
| +28.34% | 829 |
$9.51 | -$3,252.42 | 3.75K |
Aug 7 - Aug 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| -5.70% | -3.54K |
$0.13 | -$443.89 | 58.51K |
May 8
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
| +60.70% | 23.44K |
—
|
—
| 62.05K |
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MAXYGEN INC No price found
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Serina Therapeutics, Inc. (AGE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||